Cargando…
Favipiravir-based regimen for coronavirus disease 2019 pneumonia for a 47-day-old male newborn
Coronavirus disease 2019 pneumonia in the newborn is a difficult-to-treat condition. Early clinical signs of pneumonia are nonspecific and present as respiratory distress of varying severity, and tachypnea is a predominant clinical sign. A 47-day-old, asymptomatic male newborn of coronavirus disease...
Autores principales: | Moolasart, Visal, Wongsawat, Jurai, Phokhom, Priyanut, Thienthong, Varaporn |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7570769/ https://www.ncbi.nlm.nih.gov/pubmed/33117539 http://dx.doi.org/10.1177/2050313X20964046 |
Ejemplares similares
-
Risk of novel coronavirus 2019 transmission from children to caregivers: A case series
por: Wongsawat, Jurai, et al.
Publicado: (2020) -
Optimized and Non-Optimized Personal Protective Equipment Use during the COVID-19 Pandemic in Thailand: A National Cross-Sectional Survey in a Resource-Limited Setting
por: Moolasart, Visal, et al.
Publicado: (2021) -
Point prevalence survey of antibiotic use among hospitalized patients across 41 hospitals in Thailand
por: Anugulruengkitt, Suvaporn, et al.
Publicado: (2023) -
Favipiravir-induced Liver Injury in Patients with Coronavirus Disease 2019
por: Kumar, Pramod, et al.
Publicado: (2021) -
Use of Favipiravir for the Treatment of Coronavirus Disease 2019 in the Setting of Hospitel
por: Surapat, Bhitta, et al.
Publicado: (2022)